Hubei Huarong Holding Co.,Ltd.

Shanghai Stock Exchange 600421.SS

Hubei Huarong Holding Co.,Ltd. Price to Book Ratio (P/B) on January 14, 2025: 99.85

Hubei Huarong Holding Co.,Ltd. Price to Book Ratio (P/B) is 99.85 on January 14, 2025, a -38.18% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Hubei Huarong Holding Co.,Ltd. 52-week high Price to Book Ratio (P/B) is 194.54 on November 15, 2024, which is 94.83% above the current Price to Book Ratio (P/B).
Hubei Huarong Holding Co.,Ltd. 52-week low Price to Book Ratio (P/B) is 73.20 on June 06, 2024, which is -26.69% below the current Price to Book Ratio (P/B).
Hubei Huarong Holding Co.,Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 110.67.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 600421.SS

Hubei Huarong Holding Co.,Ltd.

CEO	Mr. Cai Bing Wen
IPO Date	June 7, 2004
Location	China
Headquarters	Optics Valley New World Center
Employees	107
Sector	Health Care
Industries Pharmaceuticals

Description

Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules. It also develops biological products, pharmaceuticals, environment-protection, and agricultural products, as well as related technologies. The company was formerly known as Hubei Yangfan Holding Co., Ltd. and changed its name to Hubei Huarong Holding Co.,Ltd. in November 2020. Hubei Huarong Holding Co.,Ltd. was founded in 1997 and is headquartered in Wuhan, China.

Key trends

Past 5 years